26 related articles for article (PubMed ID: 38496525)
1. Plasma cell survival: The intrinsic drivers, migratory signals, and extrinsic regulators.
Nguyen DC; Duan M; Ali M; Ley A; Sanz I; Lee FE
Immunol Rev; 2021 Sep; 303(1):138-153. PubMed ID: 34337772
[TBL] [Abstract][Full Text] [Related]
2. The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination.
Lee F; Nguyen D; Hentenaar I; Morrison-Porter A; Solano D; Haddad N; Castrillon C; Lamothe P; Andrews J; Roberts D; Lonial S; Sanz I
Res Sq; 2024 Mar; ():. PubMed ID: 38559048
[TBL] [Abstract][Full Text] [Related]
3. Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture.
Nguyen DC; Saney C; Hentenaar IT; Cabrera-Mora M; Capric V; Woodruff MC; Andrews J; Lonial S; Sanz I; Lee FE
Sci Rep; 2024 Feb; 14(1):3616. PubMed ID: 38350990
[TBL] [Abstract][Full Text] [Related]
4. Majority of human circulating plasmablasts stop blasting: A probable misnomer.
Nguyen DC; Saney C; Hentenaar IT; Cabrera-Mora M; Woodruff MC; Andrews J; Lonial S; Sanz I; Lee FE
bioRxiv; 2023 Sep; ():. PubMed ID: 37745615
[TBL] [Abstract][Full Text] [Related]
5. The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade.
Geisen UM; Rose R; Neumann F; Ciripoi M; Vullriede L; Reid HM; Berner DK; Bertoglio F; Hoff P; Hust M; Longardt AC; Lorentz T; Martini GR; Saggau C; Schirmer JH; Schubert M; Sümbül M; Tran F; Voß M; Zeuner R; Morrison PJ; Bacher P; Fickenscher H; Gerdes S; Peipp M; Schreiber S; Krumbholz A; Hoyer BF
J Med Virol; 2022 Dec; 94(12):5780-5789. PubMed ID: 35945627
[TBL] [Abstract][Full Text] [Related]
6. The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination.
Nguyen DC; Hentenaar IT; Morrison-Porter A; Solano D; Haddad NS; Castrillon C; Lamothe PA; Andrews J; Roberts D; Lonial S; Sanz I; Lee FE
medRxiv; 2024 Mar; ():. PubMed ID: 38496525
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and plasma cells: Is there long-lived protection?
Nguyen DC; Lamothe PA; Woodruff MC; Saini AS; Faliti CE; Sanz I; Lee FE
Immunol Rev; 2022 Aug; 309(1):40-63. PubMed ID: 35801537
[TBL] [Abstract][Full Text] [Related]
8. Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells.
Nguyen DC; Joyner CJ; Sanz I; Lee FE
Front Immunol; 2019; 10():2138. PubMed ID: 31572364
[TBL] [Abstract][Full Text] [Related]
9. Targeting Multiple Myeloma through the Biology of Long-Lived Plasma Cells.
Utley A; Lipchick B; Lee KP; Nikiforov MA
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751699
[TBL] [Abstract][Full Text] [Related]
10. Survival of Long-Lived Plasma Cells (LLPC): Piecing Together the Puzzle.
Lightman SM; Utley A; Lee KP
Front Immunol; 2019; 10():965. PubMed ID: 31130955
[TBL] [Abstract][Full Text] [Related]
11. Human lymphoid tissue sampling for vaccinology.
Kwiatkowska KM; Mkindi CG; Nielsen CM
Front Immunol; 2022; 13():1045529. PubMed ID: 36466924
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
